Zura Bio Limited - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ZURA Nasdaq 2830 zurabio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zura Bio Limited

3 Penny Stocks With Market Caps Over $70M Worth Watching - Jul 18th, 2025 6:05 am
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jul 17th, 2025 2:30 pm
We're Not Very Worried About Zura Bio's (NASDAQ:ZURA) Cash Burn Rate - Jul 14th, 2025 5:18 am
Zura Bio Announces Chief Financial Officer Transition - Jul 1st, 2025 4:30 am
Zura Bio to Present at the Jefferies Global Healthcare Conference - May 27th, 2025 4:30 am
Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa - May 20th, 2025 4:30 am
Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates - May 8th, 2025 4:30 am
After losing 56% in the past year, Zura Bio Limited (NASDAQ:ZURA) institutional owners must be relieved by the recent gain - Apr 24th, 2025 4:34 am
Hopeful Week For Insiders Who Bought US$1.01m Of Zura Bio Stock - Mar 26th, 2025 9:16 am
Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates - Mar 25th, 2025 4:30 am
Zura Bio to Present at the Leerink Partners Global Healthcare Conference - Feb 24th, 2025 4:30 am
We Think Zura Bio (NASDAQ:ZURA) Can Afford To Drive Business Growth - Jan 22nd, 2025 5:44 am
Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis - Dec 23rd, 2024 4:30 am
Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference - Nov 25th, 2024 4:30 am
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis - Nov 14th, 2024 2:30 pm
Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - Nov 7th, 2024 4:30 am
Zura Bio to Participate in Two Upcoming Investor Conferences in November - Oct 30th, 2024 4:30 am
Bullish Zura Bio Insiders Loaded Up On US$1.01m Of Stock - Oct 17th, 2024 8:26 am
Institutions profited after Zura Bio Limited's (NASDAQ:ZURA) market cap rose US$45m last week but private equity firms profited the most - Sep 20th, 2024 7:27 am
Zura Bio to Present at Three Upcoming Investor Conferences in September - Sep 3rd, 2024 4:00 am